Concepedia

Xueqing Hu

XH

Statistics

Publications

14

Citations

568

H-Index

12

Active since

2008

Affiliations

University of Oklahoma Health Sciences Center(Current)

The University of Texas MD Anderson Cancer Center

Xueqing Hu is an author at University of Oklahoma Health Sciences Center specializing in medicine, oncology, and ret proto-oncogene mutations.

ORCID

Publications per year

2008–2024

14

Publications

14

Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations

Vivek Subbiah, Tao Shen, S. Terzyan et al. · Annals of Oncology · 2020 · 249 citations · Full text

, , +14

Evaluation of a classroom‐based physical activity promoting programme

A. Liu, Xueqing Hu, Guansheng Ma et al. · Obesity Reviews · 2008 · 74 citations

, , +12

The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib

Tao Shen, Xueqing Hu, Xuan Liu et al. · npj Precision Oncology · 2021 · 49 citations · Full text

, , +17

Tacrolimus alleviates LPS‐induced AKI by inhibiting TLR4/MyD88/NF‐κB signalling in mice

Xueqing Hu, Wenqian Zhou, Shun Wu et al. · Journal of Cellular and Molecular Medicine · 2021 · 39 citations · Full text

, , +17

Intraparenchymal epidermoid cysts in the brain: diagnostic value of MR diffusion-weighted imaging

Xueqing Hu, C. Hu, Xiaoling Fang et al. · Clinical Radiology · 2008 · 36 citations

, , +16

1–5 of 14